NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease
The NLR pyrin domain-containing protein 3 (NLRP3) inflammasome, a multi-protein complex, produces the pro-inflammatory cytokines interleukin (IL)-1β and IL-18, which may contribute to the development of airway inflammation in chronic obstructive pulmonary disease (COPD). The aim of this study was to explore the correlation between circulating and local airway NLRP3 inflammasome activation with acute exacerbation of COPD (AECOPD). mRNA levels of NLRP3, Caspase (Casp)-1, apoptosis-associated speck-like protein containing CARD (ASC), IL-18, and IL-1β in peripheral blood mononuclear cells (PBMCs) and bronchial tissues were determined by real-time PCR in 32 smokers, 65 patients with AECOPD, 50 COPD patients in recovery stage, and 30 COPD patients in stable stage. The levels of IL-1β and IL-18 in serum and bronchoalveolar lavage fluid (BALF) supernatants were measured by ELISA. The load of six common pathogens in BALF samples were determined by real-time PCR. The potential correlation between the mRNA levels of NLRP3, Casp-1, ASC, IL-18 or IL-1β and the load of pathogens was evaluated individually. Significantly higher mRNA levels of NLRP3, Casp-1, ASC, IL-18, IL-1β and higher levels of IL-18 and IL-1β were found in patients with AECOPD than in smokers. These NLRP3 inflammasome mediators were significantly decreased when COPD patients in the same group became clinical stable. The increased mRNA levels of NLRP3 inflammasomes in bronchial tissues were positively correlated with the load of the six common pathogens in the lower respiratory tract. We conclude that systemic and local airway NLRP3 inflammasome activation is associated with the acute exacerbation, which might be predictive factors of the acute exacerbation and clinical outcomes in COPD patients.
KEY WORDSchronic obstructive pulmonary disease (COPD) NLRP3 inflammasome acute exacerbation predictive factors
Compliance with Ethical Standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics and research committee of the Affiliated Yinzhou Hospital, College of Medicine, Ningbo University, China and the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 7.Ritter, M., K. Straubinger, S. Schmidt, D.H. Busch, S. Hagner, H. Garn, C. Prazeres da Costa, and L.E. Layland. 2014. Functional relevance of NLRP3 inflammasome-mediated interleukin (IL)-1β during acute allergic airway inflammation. Clinical and Experimental Immunology 178: 212–223.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Nieto-Torres, J.L., C. Verdiá-Báguena, J.M. Jimenez-Guardeño, J.A. Regla-Nava, C. Castaño-Rodriguez, R. Fernandez-Delgado, J. Torres, V.M. Aguilella, and L. Enjuanes. 2015. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology 485: 330–339.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Li, C., H. Zhihong, L. Wenlong, L. Xiaoyan, C. Qing, L. Wenzhi, X. Siming, and L. Shengming. 2016. The NLRP3 Inflammasome Regulates Bronchial Epithelial Cell Injury and Pro-apoptosis After Exposure to Biomass Fuel Smoke. American Journal of Respiratory Cell and Molecular Biology 55 (6): 815–824.CrossRefPubMedGoogle Scholar
- 11.Müller, T., R.P. Vieira, M. Grimm, T. Dürk, S. Cicko, R. Zeiser, T. Jakob, S.F. Martin, B. Blumenthal, S. Sorichter, D. Ferrari, F. Di Virgillio, and M. Idzko. 2011. A potential role for P2X7R in allergic airway inflammation in mice and humans. American Journal of Respiratory Cell and Molecular Biology 44: 456–464.CrossRefPubMedGoogle Scholar
- 12.Faner, R., P. Sobradillo, A. Noguera, C. Gomez, T. Cruz, A. López-Giraldo, E. Ballester, N. Soler, J.I. Arostegui, P. Pelegrín, R. Rodriguez-Roisin, J. Yagüe, B.G. Cosio, M. Juan, and A. Agustí. 2016. The inflammasome pathway in stable COPD and acute exacerbations. ERJ Open Research 2: 00002–02016.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Rabe, K.F., S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, and J. Zielinski. 2007. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 176: 532–555.CrossRefPubMedGoogle Scholar
- 16.Hussain, S., S. Sangtian, S.M. Anderson, R.J. Snyder, J.D. Marshburn, A.B. Rice, J.C. Bonner, and S. Garantziotis. 2014. Inflammasome activation in airway epithelial cells after multi-walled carbon nanotube exposure mediates a profibrotic response in lung fibroblasts. Particle and Fibre Toxicology 11: 28.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Dihlmann, S., P. Erhart, A. Mehrabi, A. Nickkholgh, F. Lasitschka, D. Böckler, and M. Hakimi. 2014. Increased expression and activation of absent in melanoma 2 inflammasome components in lymphocytic infiltrates of abdominal aortic aneurysms. Molecular Medicine 20: 230–237.CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Wang, H., X. Gu, Y. Weng, T. Xu, Z. Fu, W. Peng, and W. Yu. 2015. Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease. BMC Pulmonary Medicine 15: 94. https://doi.org/10.1186/s12890-015-0094-z.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Kang, M., R.J. Homer, A. Gallo, C.G. Lee, K.A. Crothers, Sj Cho, C. Rochester, H. Cain, G. Chupp, H.J. Yoon, and J.A. Elias. 2007. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. Journal of Immunology 178: 1948–1959.CrossRefGoogle Scholar
- 29.Eltom, S., M.G. Belvisi, C.S. Stevenson, S.A. Maher, E. Dubuis, K.A. Fitzgerald, and M.A. Birrell. 2014. Role of the Inflammasome-Caspase1/11-IL-1/18Axis in Cigarette Smoke Driven Airway Inflammation: An Insight into the Pathogenesis of COPD. PLoS One 9: e112829.CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Harder, J., L. Franchi, R. Muñoz-Planillo, J.H. Park, T. Reimer, and G. Núñez. 2009. Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. Journal of Immunology 183: 5823–5829.CrossRefGoogle Scholar
- 33.McNeela, E.A., A. Burke, D.R. Neill, C. Baxter, V.E. Fernandes, D. Ferreira, S. Smeaton, R. El-Rachkidy, R.M. McLoughlin, A. Mori, B. Moran, K.A. Fitzgerald, J. Tschopp, V. Pétrilli, P.W. Andrew, A. Kadioglu, and E.C. Lavelle. 2010. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathogens 6: e1001191.CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Perret, M., C. Badiou, G. Lina, S. Burbaud, Y. Benito, M. Bes, V. Cottin, F. Couzon, C. Juruj, O. Dauwalder, N. Goutagny, B.A. Diep, F. Vandenesch, and T. Henry. 2012. Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. Cellular Microbiology 14: 1019–1036.CrossRefPubMedGoogle Scholar
- 35.Willingham, S.B., I.C. Allen, D.T. Bergstralh, W.J. Brickey, M.T. Huang, D.J. Taxman, J.A. Duncan, and J.P. Ting. 2009. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. Journal of Immunology 183: 2008–2015.CrossRefGoogle Scholar
- 37.Rotta Detto Loria, J., K. Rohmann, D. Droemann, P. Kujath, J. Rupp, T. Goldmann, and K. Dalhoff. 2013. Non-typeable haemophilus influenzae infection upregulates the NLRP3 inflammasome and leads to Caspase-1-dependent secretion of interleukin-1β—A possible pathway of exacerbations in COPD. PLoS One 8: e66818.CrossRefPubMedPubMedCentralGoogle Scholar